Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 856704, 7 pages
http://dx.doi.org/10.1155/2015/856704
Research Article

The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis

1Department of Hematology, The Myeloma and Lymphoma Center, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China
2Peking University People’s Hospital and Peking University Institute of Hematology, No. 11 Xizhimen South Street, Beijing 100044, China
3Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, 8 Workers Stadium South Road, Beijing 100020, China

Received 23 July 2015; Accepted 13 September 2015

Academic Editor: Abdel Kareem Azab

Copyright © 2015 Jing Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jing Lu, Jin Lu, Aijun Liu, et al., “The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis,” BioMed Research International, vol. 2015, Article ID 856704, 7 pages, 2015. https://doi.org/10.1155/2015/856704.